STRATA Skin Sciences, Inc. (NASDAQ:SSKN – Get Free Report) saw a large increase in short interest in February. As of February 15th, there was short interest totalling 600 shares, an increase of 20.0% from the January 31st total of 500 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 6,300 shares, the short-interest ratio is currently 0.1 days.
Analysts Set New Price Targets
Separately, Maxim Group initiated coverage on STRATA Skin Sciences in a research report on Thursday, February 27th. They issued a “buy” rating and a $6.00 target price on the stock.
View Our Latest Analysis on SSKN
STRATA Skin Sciences Price Performance
STRATA Skin Sciences Company Profile
STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
Read More
- Five stocks we like better than STRATA Skin Sciences
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- 2 Oversold Stocks With Major Reasons to Rebound
- Why Invest in 5G? How to Invest in 5G Stocks
- Robinhood’s Rally: Is Global Expansion the Next Big Catalyst?
- What is MarketRank™? How to Use it
- Eli Lilly Pours $27B Into U.S. Growth—What It Means for Investors
Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.